Validation of the breast evaluation questionnaire for breast hypertrophy and breast reduction

2018 ◽  
Vol 52 (5) ◽  
pp. 274-281
Author(s):  
Richard Lewin ◽  
Anna Elander ◽  
Jonas Lundberg ◽  
Emma Hansson ◽  
Andri Thorarinsson ◽  
...  
Keyword(s):  
Breast Reduction ◽  
Breast Hypertrophy ◽  
Evaluation Questionnaire

The Impact of Surgical Breast Reduction on the Postural Control of Women with Breast Hypertrophy

2013 ◽  
Vol 37 (2) ◽  
pp. 321-326 ◽  
Author(s):  
Alessandra F. Barbosa ◽  
Patricia H. Lavoura ◽  
Catarina C. Boffino ◽  
Cássio M. Siqueira ◽  
Márcio P. Costa ◽  
...  
Keyword(s):  
Postural Control ◽  
Breast Reduction ◽  
Breast Hypertrophy ◽  
The Impact

scholarly journals Outcomes and Outcome Measures in Breast Reduction Mammaplasty: A Systematic Review

2019 ◽  
Vol 40 (4) ◽  
pp. 383-391 ◽  
Author(s):  
Daniel Waltho ◽  
Lucas Gallo ◽  
Matteo Gallo ◽  
Jessica Murphy ◽  
Andrea Copeland ◽  
...  
Keyword(s):  
Outcome Measures ◽  
Breast Reduction ◽  
Reduction Mammaplasty ◽  
Life Outcomes ◽  
Breast Hypertrophy ◽  
Level Of Evidence ◽  
Outcome Set ◽  
Patient Reported ◽  
Clinical Measures

Abstract Background Reduction mammaplasty remains critical to the treatment of breast hypertrophy. No technique has been shown to be superior; however, comparison between studies is difficult due to variation in outcome reporting. Objectives The authors sought to identify a comprehensive list of outcomes and outcome measures in reduction mammaplasty. Methods A comprehensive computerized search was performed. Included studies were randomized or nonrandomized controlled trials involving at least 100 cases of female breast hypertrophy and patients of all ages who underwent 1 or more defined reduction mammaplasty technique. Outcomes and outcome measures were extracted and tabulated. Results A total 106 articles were eligible for inclusion; 57 unique outcomes and 16 outcome measures were identified. Frequency of patient-reported and author-reported outcomes were 44% and 88%, respectively. Postoperative complications were the most frequently reported outcome (82.2%). Quality-of-life outcomes were accounted for in 37.7% of studies. Outcome measures were either condition-specific or generic; frequencies were as low as 1% and as high as 5.6%. Five scales were formally assessed in the breast reduction populations. Clinical measures were defined in 15.1% of studies. Conclusions There is marked heterogeneity in reporting of outcomes and outcome measures in the literature. A standardized outcome set is needed to compare outcomes of various reduction mammaplasty techniques. Level of Evidence: 4

scholarly journals Giant Breast Hypertrophy in Juvenile: A Rare Case

2020 ◽  
Vol 14 (2) ◽  
pp. 60
Author(s):  
Dila Junita ◽  
Edmond Rukmana Wikanta
Keyword(s):  
Breast Reduction ◽  
Early Stage ◽  
Psychosocial Problems ◽  
Reduction Mammoplasty ◽  
Treatment Modalities ◽  
Breast Hypertrophy ◽  
Breast Reduction Surgery ◽  
Benign Condition ◽  
Breast Enlargement ◽  
Severe Back Pain

Introduction: Juvenile hypertrophy of the breast (JHB) is a benign condition that can lead to gigantomastia in adolescence. The development of breast enlargement in adolescence can cause both physical and psychosocial problems. Therefore, appropriate investigation and proper management at an early stage of the disease are very important. One of the treatment modalities is breast reduction surgery which ideal and offers an improvement in the quality of life. Case Presentation: A 13-year-old female with massive bilateral breast enlargement for a period of 8 months. The patient also complained of severe back pain and neck discomfort since her breast progressively enlarged. Psychosocial problems were recorded. Right breast reduction was performed and closed with inverted-T mammoplasty. The post-operative period was uneventful, and the patient was discharged on day 5 after the operation. Conclusions: Reduction mammoplasty is well accepted by adolescents with juvenile breast hypertrophy and can improve physical and psychological outcomes.

Unusual Keloid Formation at the Mammostat Location Following Breast Reduction

2017 ◽  
Vol 34 (3) ◽  
pp. 118-122
Author(s):  
L. Adjadj ◽  
T. Schmitt ◽  
C. Fenoll ◽  
R. Makhoul ◽  
P. Levan
Keyword(s):  
High Risk ◽  
Risk Ratio ◽  
Revision Surgery ◽  
Breast Reduction ◽  
Reduction Mammoplasty ◽  
Breast Hypertrophy ◽  
Keloid Scarring ◽  
Keloid Scars ◽  
Keloid Formation ◽  
Intralesional Injections

We report the case of a patient who developed keloid scarring associated with Mammostat-induced skin trauma during reduction mammoplasty. A 32-year-old patient consulted for breast hypertrophy and developed from the fourth postoperative month significant keloid scars on skin shears caused by dermal stretching techniques used during de-epithelialization. The Mammostat-related scars were keloid, while those found on old skin incisions were only enlarged and slightly hypertrophic. We followed up this patient for 7 years. During this time, she received the following local treatments: scar kneading, silicone dressings, intralesional injections of corticosteroids, and potent dermocorticosteroids. After balancing the benefit/risk ratio of a possible revision surgery for resection and plasty of her keloid scars, we opted for therapeutic abstention. In patients at high risk of keloids, we recommend a soft de-epithelialization causing no skin shear, performed by manual tensioning of the dermis.

scholarly journals Does breast reduction surgery improve health-related quality of life? A prospective cohort study in Australian women

BMJ Open ◽  
2020 ◽  
Vol 10 (2) ◽  
pp. e031804
Author(s):  
Tamara Crittenden ◽  
David I Watson ◽  
Julie Ratcliffe ◽  
Philip A Griffin ◽  
Nicola R Dean
Keyword(s):  
Quality Of Life ◽  
Breast Reduction ◽  
Health Related Quality ◽  
Breast Hypertrophy ◽  
Breast Reduction Surgery ◽  
Sf 36 ◽  
Related Quality ◽  
Health Related

ObjectivesTo assess the health burden of breast hypertrophy and the comparative effectiveness of breast reduction surgery in improving health-related quality of life.DesignProspective cohort study.SettingA major public tertiary care hospital in Australia.ParticipantsWomen with symptomatic breast hypertrophy who underwent breast reduction surgery were followed for 12 months. A comparison control cohort comprised women with breast hypertrophy who did not undergo surgery.InterventionsBilateral breast reduction surgery for women in the surgical cohort.Main outcome measuresThe primary outcome measure was health-related quality of life measured preoperatively and at 3, 6 and 12 months postoperatively using the Short Form-36 (SF-36) questionnaire. Secondary outcome measures included post-surgical complications.Results209 patients in the surgical cohort completed questionnaires before and after surgery. 124 patients in the control hypertrophy cohort completed baseline and 12-month follow-up questionnaires. At baseline, both groups had significantly lower scores compared with population norms across all scales (p<0.001). In the surgical cohort significant improvements were seen across all eight SF-36 scales (p<0.001) following surgery. Within 3 months of surgery scores were equivalent to those of the normal population and this improvement was sustained at 12 months. SF-36 physical and mental component scores both significantly improved following surgery, with a mean change of 10.2 and 9.2 points, respectively (p<0.001). In contrast, SF-36 scores for breast hypertrophy controls remained at baseline across 12 months. The improvement in quality of life was independent of breast resection weight and body mass index.ConclusionBreast reduction significantly improved quality of life in women with breast hypertrophy. This increase was most pronounced within 3 months of surgery and sustained at 12-month follow-up. This improvement in quality of life is comparable to other widely accepted surgical procedures. Furthermore, women benefit from surgery regardless of factors including body mass index and resection weight.

Sign in / Sign up

Export Citation Format

Share Document